Epilepsy associated with chromosomal disorders.

Area of Science:

• Neurology
• Genetics
• Clinical Neurophysiology

Background:

• Chromosomal disorders often manifest with significant neurological symptoms, primarily developmental delay and epilepsy.
• Epilepsy associated with these genetic conditions substantially affects patient morbidity, quality of life, and neurodevelopmental trajectories.
• Specific chromosomal syndromes, including Angelman syndrome, ring chromosome 20, Down syndrome, and Dup15q syndrome, exhibit distinct electroclinical features.

Purpose of the Study:

• To review the prevalence, onset, seizure types, electroencephalographic (EEG) characteristics, and treatment strategies for epilepsy in major chromosomal disorders.
• To emphasize the critical role of understanding EEG findings for tailoring interventions and optimizing outcomes in affected individuals.
• To highlight how recognizing specific electroclinical patterns can enhance diagnostic accuracy and epilepsy management.

Main Methods:

• This study is a review of existing literature on epilepsy in chromosomal disorders.
• It synthesizes information on the clinical presentation and EEG findings associated with conditions such as Angelman syndrome, ring chromosome 20, Down syndrome, and Dup15q syndrome.
• The review examines seizure types, onset, and treatment approaches reported in the literature.

Main Results:

• Angelman syndrome is characterized by epilepsy with atypical absences and myoclonic seizures, often accompanied by rhythmic delta activity on EEG.
• Ring chromosome 20 syndrome typically presents with focal frontal seizures and non-convulsive status epilepticus.
• Down syndrome exhibits a biphasic epilepsy pattern, from infantile spasms to late-onset myoclonic epilepsy, while Dup15q syndrome is associated with drug-resistant epilepsy and specific EEG abnormalities like beta rhythms and hypsarrhythmia.

Conclusions:

• Understanding the electroencephalographic (EEG) patterns associated with epilepsy in chromosomal disorders is crucial for effective clinical management.
• Identifying these specific electroclinical profiles can lead to improved diagnosis and targeted treatment strategies.
• Optimizing epilepsy management in chromosomal disorders enhances patient care and improves the accuracy of prognosis.